{"id":426,"date":"2024-11-07T15:39:53","date_gmt":"2024-11-07T15:39:53","guid":{"rendered":"https:\/\/stemvacs.therapeuticsolutionsint.com\/?page_id=426"},"modified":"2024-11-07T15:41:48","modified_gmt":"2024-11-07T15:41:48","slug":"neoplasia-stemvacs-b","status":"publish","type":"page","link":"https:\/\/stemvacs.therapeuticsolutionsint.com\/index.php\/neoplasia-stemvacs-b\/","title":{"rendered":"Neoplasia – StemVacs-B"},"content":{"rendered":"

[et_pb_section fb_built=”1″ admin_label=”Header” _builder_version=”4.21.0″ _module_preset=”default” background_color=”gcid-3cfc8c0c-5557-4a5d-9dab-24e78d615311″ custom_padding=”61px|||||” collapsed=”on” global_colors_info=”{%22gcid-3cfc8c0c-5557-4a5d-9dab-24e78d615311%22:%91%22background_color%22%93}” theme_builder_area=”post_content”][et_pb_row _builder_version=”4.24.3″ _module_preset=”default” custom_padding=”0px||0px|||” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_column type=”4_4″ _builder_version=”4.24.3″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_text _builder_version=”4.24.3″ _module_preset=”default” custom_margin=”-47px|||||” custom_padding=”2px||0px|||” global_colors_info=”{}” theme_builder_area=”post_content”]<\/p>\n

The following list of cancer immunotherapies<\/strong> are available for licensing under U.S. Patent Publication No.: 20220267730<\/span><\/a>.<\/span><\/p>\n

Ex Vivo Generation of Immunocytes Recognizing Brother of the Regulator of Imprinted Sites (BORIS) Expressing Cancer Stem Cells<\/strong><\/p>\n

\n
\n
\n
Abstract<\/div>\n
\n
Disclosed are means, methods and compositions of matter useful for induction of immunity towards cancer stem cells by providing a dendritic cell, wherein said dendritic cells express BORIS and\/or peptides derived from BORIS, wherein said dendritic cell is cultured in the presence of one or more immunocytes. In one embodiment said dendritic cells are derived from umbilical cord blood sources and allogeneic to T cells, which are expanded ex vivo and used for the purposes of immunotherapy.<\/span><\/section>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.24.3″ _module_preset=”default” custom_margin=”-99px|auto||auto||” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_column type=”4_4″ _builder_version=”4.24.3″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_text _builder_version=”4.24.3″ _module_preset=”default” custom_margin=”-185px|||||” custom_padding=”80px|||||” hover_enabled=”0″ global_colors_info=”{}” theme_builder_area=”post_content” sticky_enabled=”0″]<\/p>\n


\n
\n